9 Meters Biopharma, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €9.44M
    R&D expenses
    €27.83M
    EBITDA
    -€36.70M
    D&A
    €148.44K
    EBIT
    -€37.27M
    Interest expenses
    €2.99M
    EBT
    -€39.71M
    Tax expenses
    €3.02M
    Net income
    -€39.71M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €2.56M
    Changes in working capital
    €1.77M
    Operating cash flow
    -€31.96M
    Capex
    €2.44K
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€2.44K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €4.29M
    Debt repayment
    €0.00
    Other financing cash flow
    €7.48M
    Net financing cash flow
    €4.68M
    Foreign exchange effects
    €1.87M
    Net change in cash
    -€25.41M
    Cash at end of period
    €6.54M
    Free cash flow
    -€31.95M

    Balance sheet

    Cash and cash equivalents
    €5.95M
    Cash and short-term investments
    €5.95M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €1.35M
    Total current assets
    €7.89M
    Property, plant & equipment
    €91.60K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €7.70K
    Total non-current assets
    €99.30K
    Total assets
    €7.99M
    Accounts payable
    €3.63M
    Short-term debt
    €4.41M
    Other current liabilities
    €5.33M
    Total current liabilities
    €13.37M
    Long-term debt
    €29.84K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €29.84K
    Total liabilities
    €13.40M
    Common stock
    €1.23K
    Retained earnings
    -€194.32M
    Other equity
    €0.00
    Total equity
    -€5.40M
    Total liabilities and shareholders' equity
    €7.99M

    Company information

    Market capitalization
    €890.47K
    Employees
    10
    Enterprise Value
    €8.13M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    734.7% Much better than peer group: -74.9%
    ROA
    -497.0% Much worse than peer group: -320.0%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -3,588.9%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€3.97M

    Notifications